Case Study: Fortune 100 Pharmaceutical Company achieves vaccine supply chain visibility with Altana

How Value Chain Visibility Protects Crucial Vaccine Supplies

A Fortune 100 pharmaceutical company was struggling with major blindspots in its product value chains, particularly for its two highest revenue-earning vaccines. Unable to see beyond its direct suppliers, the company lacked the visibility needed to guarantee the security and delivery of crucial supplies. To address this challenge, the company turned to Altana and its platform, the Altana Atlas.

By connecting to the Altana Atlas, the company gained an unprecedented view of its multi-tier supply chain, including facility locations and shipment-level data. This visibility allowed Altana to provide critical, AI-powered decision support. The solution enabled the company to proactively mitigate risks, such as a tier 3 supplier's insolvency, and understand the root cause of a plastic raw material shortage, preventing widespread product shortages and ensuring the reliable production of life-saving vaccines.